HLS Therapeutics Inc. (HLS.TO) TSX

4.47

-0.11(-2.40%)

Updated at January 14 11:05AM

Currency In CAD

Valuation

Market Cap86.95M
Enterprise Value135.95M
P/E Ratio-7.48
PEG Ratio-1.17
Price/Sales Ratio1.88
Price/Book Ratio1.71
Enterprise/Revenue2.66
Enterprise/EBITDA9.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.13

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.21

Income Statement

Revenue56.62M
Revenue/Share1.78
Gross Profit47.62M
EBITDA17.22M
Net Income-19.66M
Diluted EPS-0.62

Balance Sheet

Total Cash10.78M
Total Cash/Share0.34
Total Debt54.09M
Total Debt/Equity0.88
Current Ratio1.17
Book Value Per Share1.97

Price History

52-Week Change18.35
52-Week High5.77
52-Week Low3.79
Moving Average 50 Days4.97
Moving Average 200 Days4.99

Statistics

Average Volume10,043
Shares Outstanding31.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A